Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 434 Carcinoma, Non-Small-Cell Lung 360 Neoplasms 339 Prostatic Neoplasms 276 Colorectal Neoplasms 264 Multiple Myeloma 206 Lung Neoplasms 195 Neoplasm Metastasis 179 Leukemia, Myeloid, Acute 160 Ovarian Neoplasms 155 Pancreatic Neoplasms 152 Squamous Cell Carcinoma of Head and Neck 138 Melanoma 126 Recurrence 104 Head and Neck Neoplasms 99 Glioblastoma 99 Carcinoma, Renal Cell 98 Endometrial Neoplasms 96 Carcinoma, Hepatocellular 93 Lymphoma, Non-Hodgkin 92 Precursor Cell Lymphoblastic Leukemia-Lymphoma 91 Lymphoma 91 Triple Negative Breast Neoplasms 90 Stomach Neoplasms 88 Uterine Cervical Neoplasms 85 Brain Neoplasms 85 Lymphoma, Large B-Cell, Diffuse 80 Urinary Bladder Neoplasms 77 Glioma 74 Leukemia, Lymphocytic, Chronic, B-Cell 73

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Liver Cancers × 30 days × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡